abiraterone,olaparib
astrazeneca,merck
['abira', 'prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'olaparib', 'abiraterone']
updated survival data from #olaparib and #abiraterone in #mcrpc #prostatecancer is presented as positive #gu23 despite ci =/&gt;1.0 the data in the non-mutated patients remains an issue, especially given toxicity of #parp inhibition 
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR)  & #immunotherapy. Views are my own & do not represent the National Cancer Institute